Details for New Drug Application (NDA): 073609
✉ Email this page to a colleague
The generic ingredient in PINDOLOL is pindolol. There are eleven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the pindolol profile page.
Summary for 073609
| Tradename: | PINDOLOL |
| Applicant: | Ani Pharms |
| Ingredient: | pindolol |
| Patents: | 0 |
Pharmacology for NDA: 073609
| Mechanism of Action | Adrenergic beta-Antagonists |
Medical Subject Heading (MeSH) Categories for 073609
Suppliers and Packaging for NDA: 073609
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| PINDOLOL | pindolol | TABLET;ORAL | 073609 | ANDA | Marlex Pharmaceuticals, Inc. | 10135-743 | 10135-743-01 | 100 TABLET in 1 BOTTLE (10135-743-01) |
| PINDOLOL | pindolol | TABLET;ORAL | 073609 | ANDA | Marlex Pharmaceuticals, Inc. | 10135-744 | 10135-744-01 | 100 TABLET in 1 BOTTLE (10135-744-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
| Approval Date: | Mar 29, 1993 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
| Approval Date: | Mar 29, 1993 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
